{
    "id": "90f1b2dd-1f14-e002-60ff-7a39a009b6e3",
    "indications": {
        "text": "ambrisentan tablets indicated treatment pulmonary arterial hypertension ( pah ) ( group 1 ) adult patients : improve exercise ability delay worsening . establishing effectiveness included predominantly patients functional class ii\u2013iii symptoms etiologies idiopathic heritable pah ( 60 % ) pah associated connective tissue diseases ( 34 % ) .",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "initiate treatment 5 mg daily ( 2.1 ) . titrate 4-week intervals needed tolerated ( 2.1 ) . split , crush , chew tablets ( 2.1 ) .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "ambrisentan film-coated tablets supplied follows : 5 mg tablet pale pink , biconvex , beveled edged , arc square film-coated tablet . engraved `` apo `` one side , `` a5 `` side . bottles 30 tablets ndc 60505-4552-3 blisters 10 ( 1 x 10 blister pack ) ndc 60505-4552-0 blisters 30 ( 3 x 10 blister pack ) ndc 60505-4552-1 10 mg tablet deep pink , biconvex , oval film-coated tablet . engraved `` apo `` one side , `` a10 `` side . bottles 30 tablets ndc 60505-4553-3 blisters 10 ( 1 x 10 blister pack ) ndc 60505-4553-0 blisters 30 ( 3 x 10 blister pack ) ndc 60505-4553-1",
    "adverseReactions": "pregnancy ( 4.1 ) idiopathic pulmonary fibrosis ( 4.2 )",
    "ingredients": [
        {
            "name": "AMBRISENTAN",
            "code": "HW6NV07QEC",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_135949"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "FD&C RED NO. 40",
            "code": "WZB9127XOA"
        },
        {
            "name": "ALUMINUM OXIDE",
            "code": "LMI26O6933",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_25741"
        },
        {
            "name": "FD&C YELLOW NO. 6",
            "code": "H77VEI93A8"
        },
        {
            "name": "POLYETHYLENE GLYCOL 3350",
            "code": "G2M7P15E5P",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "POLYVINYL ALCOHOL, UNSPECIFIED",
            "code": "532B59J990",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        }
    ],
    "organization": "Apotex Corp.",
    "name": "Ambrisentan",
    "effectiveTime": "20250429",
    "indications_original": "Ambrisentan tablets are indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) in adult patients:\n                  \n                     To improve exercise ability and delay clinical worsening. \n                  \n                  Studies establishing effectiveness included predominantly patients with WHO Functional Class II\u2013III symptoms and etiologies of idiopathic or heritable PAH (60%) or PAH associated with connective tissue diseases (34%).",
    "contraindications_original": "Initiate treatment at 5 mg once daily ( 2.1 ). Titrate at 4-week intervals as needed and tolerated ( 2.1 ). Do not split, crush, or chew tablets ( 2.1 ).",
    "warningsAndPrecautions_original": "Ambrisentan film-coated tablets are supplied as follows:\n                  Each 5 mg tablet is pale pink, biconvex, beveled edged, arc square film-coated tablet. Engraved \"APO\" on one side, \"A5\" on the other side.\n                  Bottles of 30 tablets NDC 60505-4552-3 Blisters of 10 (1 x 10 blister pack) NDC 60505-4552-0 Blisters of 30 (3 x 10 blister pack) NDC 60505-4552-1\n                  Each 10 mg tablet is deep pink, biconvex, oval film-coated tablet. Engraved \"APO\" on one side, \"A10\" on the other side.\n                  Bottles of 30 tablets NDC 60505-4553-3 Blisters of 10 (1 x 10 blister pack) NDC 60505-4553-0 Blisters of 30 (3 x 10 blister pack) NDC 60505-4553-1",
    "adverseReactions_original": "Pregnancy ( 4.1 ) Idiopathic Pulmonary Fibrosis ( 4.2 )",
    "drug": [
        {
            "name": "Ambrisentan",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_135949"
        }
    ]
}